218 related articles for article (PubMed ID: 9723711)
1. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.
Nydam T; Wade TK; Yadati S; Gabriel JL; Barisas BG; Wade WF
Int Immunol; 1998 Aug; 10(8):1237-49. PubMed ID: 9723711
[TBL] [Abstract][Full Text] [Related]
2. Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation.
Yadati S; Nydam T; Demian D; Wade TK; Gabriel JL; Barisas BG; Wade WF
Immunol Lett; 1999 Mar; 67(1):47-55. PubMed ID: 10217205
[TBL] [Abstract][Full Text] [Related]
3. The immune function of MHC class II molecules mutated in the putative superdimer interface.
Hayball JD; Lake RA
Mol Cell Biochem; 2005 May; 273(1-2):1-9. PubMed ID: 16013435
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics of point mutated I-A(k) molecules expressed on lymphocytes.
Munnelly HM; Brady CJ; Hagen GM; Horvat RD; Wade WF; Roess DA; Barisas BG
Immunol Lett; 2001 Jul; 77(3):187-96. PubMed ID: 11410253
[TBL] [Abstract][Full Text] [Related]
5. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
6. The structure of MHC class II: a role for dimer of dimers.
Schafer PH; Pierce SK; Jardetzky TS
Semin Immunol; 1995 Dec; 7(6):389-98. PubMed ID: 8775464
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation to specific T cells by Ia molecules selectively altered by site-directed mutagenesis.
Brett SJ; McKean D; York-Jolley J; Berzofsky JA
Int Immunol; 1989; 1(2):130-40. PubMed ID: 2518656
[TBL] [Abstract][Full Text] [Related]
8. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
Clatza A; Bonifaz LC; Vignali DA; Moreno J
J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
[TBL] [Abstract][Full Text] [Related]
9. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
[TBL] [Abstract][Full Text] [Related]
10. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
Lindstedt R; Monk N; Lombardi G; Lechler R
J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
[TBL] [Abstract][Full Text] [Related]
11. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
[TBL] [Abstract][Full Text] [Related]
12. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of two DR alpha residues involved in dimers of HLA-DR molecules.
Goodman S; Sawada T; Barbosa JA; Cole B; Pergolizzi R; Silver J; Mellins E; Chang MD
J Immunol; 1995 Aug; 155(3):1210-7. PubMed ID: 7636189
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the antigen binding region of an MHC class II molecule.
Rosloniec EF; Beard KS; Freed JH
Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
[TBL] [Abstract][Full Text] [Related]
15. Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.
Undale AH; van den Elsen PJ; Celis E
Int Immunol; 2004 Oct; 16(10):1523-33. PubMed ID: 15351785
[TBL] [Abstract][Full Text] [Related]
16. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
17. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
18. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12.
Correale J; McMillan M; Li S; McCarthy K; Le T; Weiner LP
J Neuroimmunol; 1997 Jan; 72(1):27-43. PubMed ID: 9003243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
